- Home
- LNKS vs ADXN Comparison
LNKS vs ADXN Comparison
Compare LNKS & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKS
- ADXN
- Stock Information
- Founded
- LNKS 1995
- ADXN 2002
- Country
- LNKS Malaysia
- ADXN Switzerland
- Employees
- LNKS N/A
- ADXN N/A
- Industry
- LNKS
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- LNKS
- ADXN Health Care
- Exchange
- LNKS NYSE
- ADXN Nasdaq
- Market Cap
- LNKS 8.7M
- ADXN 8.1M
- IPO Year
- LNKS 2024
- ADXN N/A
- Fundamental
- Price
- LNKS $0.60
- ADXN $10.23
- Analyst Decision
- LNKS
- ADXN Strong Buy
- Analyst Count
- LNKS 0
- ADXN 1
- Target Price
- LNKS N/A
- ADXN $30.00
- AVG Volume (30 Days)
- LNKS 239.8K
- ADXN 3.8K
- Earning Date
- LNKS 06-17-2025
- ADXN 06-17-2025
- Dividend Yield
- LNKS N/A
- ADXN N/A
- EPS Growth
- LNKS N/A
- ADXN N/A
- EPS
- LNKS N/A
- ADXN 0.08
- Revenue
- LNKS $5,088,489.00
- ADXN $452,495.00
- Revenue This Year
- LNKS N/A
- ADXN $86.57
- Revenue Next Year
- LNKS N/A
- ADXN N/A
- P/E Ratio
- LNKS N/A
- ADXN $0.93
- Revenue Growth
- LNKS N/A
- ADXN N/A
- 52 Week Low
- LNKS $0.45
- ADXN $6.51
- 52 Week High
- LNKS $10.27
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- LNKS N/A
- ADXN 73.57
- Support Level
- LNKS N/A
- ADXN $8.08
- Resistance Level
- LNKS N/A
- ADXN $8.20
- Average True Range (ATR)
- LNKS 0.00
- ADXN 0.23
- MACD
- LNKS 0.00
- ADXN 0.11
- Stochastic Oscillator
- LNKS 0.00
- ADXN 71.04
About LNKS LINKERS INDUSTRIES LIMITED
Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.